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In recent years, there have been dramatic advances in technol-
ogies to profile molecules in single cells. Efforts to profile single10 Developmental Cell 49, April 8, 2019 ª 2019 Elsevier Inc.
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et al., 1990; Eberwine et al., 1992) and Norman Iscove (Bradycommons.org/licenses/by/4.0/).
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Perspectiveet al., 1990). In the past few years, the field has been transformed
by a series of advances that combine next-generation
sequencing and massively parallel processing of single cells,
first with single-cell RNA sequencing (RNA-seq) (Macosko
et al., 2015; Klein et al., 2015; Gierahn et al., 2017), chromatin or-ganization (Buenrostro et al., 2015), and sequence variation
(Yuan et al., 2017) as well as in combination for multimodal read-
outs (Stuart and Satija, 2019). Other experimental technologies
under development in proteomics (Specht, and Slavov, 2018),
chromosomal conformation (Lando et al., 2018), dynamic cellDevelopmental Cell 49, April 8, 2019 11
Figure 1. Compiling a Pediatric Single-Cell
Atlas
A pediatric single-cell atlas can consist of multi-
omics data from hundreds to many thousands of
cells isolated from multiple tissues from normally
developing and disease-affected individuals. Single
cells can be grouped into cell types that have unique
molecular profiles representing primary programs
for that cell type as well as sub-state-specific addi-
tional programming. The utility of a single-cell atlas is
the possibility to map molecular signatures driving
developmental, physiological, and pathological
processes. Thus, single cell-based signatures can
reveal the roles and responses of multiple cell line-
ages that dictate a given organ’s and/or tissue’s
collective biology.
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Perspectiveimaging (Fermie et al., 2018), and lineage tracing (Woodworth
et al., 2017) present great promise for studying transient pro-
cesses in single cells that complement longstanding histological
characterization methods. These technologies can provide
views into cellular and tissue physiology and pathology that
would be only apparent at single-cell resolution (Figure 1), with
exceptional potential for producing transformative insights
across fields such as developmental biology, genetics, disease
pathology, and evolutionary biology (Baslan and Hicks, 2017;
Marioni and Arendt, 2017; Behjati et al., 2018).
Given these advances, whole-organism tissue maps at the
single-cell level are now feasible (Cao et al., 2017; Sebe´-Pedro´s
et al., 2018; Plass et al., 2018; Tabula Muris Consortium et al.,
2018). A case for the creation of a comprehensive human cell
atlas, including the scientific history, technologies, challenges,
and promise for a project of that scale has been recently well
described (Regev et al., 2017; Regev et al., 2018). The construc-
tion of the Human Cell Atlas (HCA), which focuses on single-cell
profiles and spatial characterization of all adult, pediatric, and
human developmental tissues, systems, and organs, is now un-
derway, and is organized under a global ‘‘coalition of the willing’’
where researchers will generate data under different funding
sources to be deposited into a central data coordination platform
(Rozenblatt-Rosen et al., 2017; Regev et al., 2018). Across the
world, multiple initiatives will contribute to the creation of a hu-
man cell atlas, as well as to applications in specific disease
areas. For example, the National Institutes of Health (NIH) sup-
ports programs such as the Human Biomolecular Atlas Program
(HuBMAP), the Human Tumor Atlas Network (HTAN), and the
BRAIN Initiative Cell Census Network programs. However, while
the Pediatric Cell Atlas (PCA) is a cornerstone of the full HCA
(Regev et al., 2018), with few exceptions (INSERM, 2018;
MRC, 2018; LungMap, 2019) to datemost initiatives do not focus
on normal pediatric tissues.
The Case for a Pediatric Cell Atlas
Support for research on the health of children still proportionally
lags behind that for adults, including in funding from the NIH (Git-
terman et al., 2018a, 2018b). The inevitable scientific advances
driven by the HCA are expected to profoundly influence transla-
tional and precision medicine research (Shalek and Benson,
2017). Likewise, developmental atlases will offer new insight12 Developmental Cell 49, April 8, 2019into the unique molecular and cellular processes operating dur-
ing embryonic and fetal stages (Behjati et al., 2018). However,
without a systematic inclusion of children in the current atlassing
endeavors, advancements in pediatric precision medicine and
therapeutic development will continue to fall behind. To also
secure these breakthrough discoveries for children, we propose
a longitudinal pediatric component within the HCA consortium, a
PCA. The plan for a PCAwas originally outlined in theHumanCell
Atlas White Paper (Regev et al., 2018) to represent a distributed
and interdisciplinary research effort into studying the unique
biology of children in the context of child health and human
development (Figure 2). We expect the data generated from
healthy tissues for a PCA would help to directly address many
important questions in biology and medicine, some of which
we discuss below.
How Do Cell-Specific Developmental Programs Vary
over the Human Lifespan?
Embryonic, fetal, juvenile, adolescent, and adult tissues have
unique classes of gene expression and developmental programs
(Ranzoni andCvejic, 2018). This iswell demonstrated in theFunc-
tional Annotation of the Mammalian Genome (FANTOM5) collec-
tion, which has utilized CAGE (Cap Analysis of Gene Expression)
sequencing fromall major organs, primary cell types, and 30 time
courses of cellular differentiation (Lizio et al., 2015). It is believed
that disruptions to developmental programs operating during
fetal and postnatal growth may strongly influence health later in
life, especially in metabolic, respiratory, and cardiovascular sys-
tems (Barker, 2004; Hanson, andGluckman, 2014; Visentin et al.,
2014), but it is not yet clear how these effects carry forward in tis-
sues from early development to adulthood. Epigenetic patterns
differ between stem-like and differentiated cell types, but it is un-
clear how lineage-specific and somatic stem cells are altered
during postnatal maturation, aging, and as a function of environ-
mental exposures (Meissner et al., 2008). Furthermore, despite
technological advancements inmapping epigenetic landscapes,
the epigenetic factors that drive tissue maturation and aging
remain largely undefined (Todhunter et al., 2018).
Other open questions include how stage-specific differences
in healthy tissues vary by internal and external factors, such as
growth factor signaling, or how nutritional and environmental
factors may impact regulatory mechanisms. In Figure 3, we
show how a stage-specific emphasis on single-cell healthy
Figure 2. Potential Applications for a PCA
The PCA has the potential to map and illuminate the cellular basis of normal and abnormal development, cell- and organ-level differentiation, and compensatory
and causal processes of disease.
(A) Healthy children are frequently in a global state of growth activation compared to adults through the effects of growth factors, leading to profound impacts on
gene expression and cell and tissue interactions, especially in the context of perturbations due to genetics, acquired somatic mutations, environment, infectious
disease, and pharmacologics.
(B) All of the outputs of a pediatric single-cell atlas are interrelated to provide a holistic outlook on how cells and tissues interact, differentiate, and function with
each other in times of normal versus disease states.
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Perspectivetissue atlas data can be used to derive novel modules of differen-
tially expressed genes, revealing new insights into pathways and
networks of fundamental importance that distinguish between
prenatal, postnatal, and adult-stage differentiated neurons. As
further shown in Figure 4, even a simple comparative re-analysis
of late fetal-versus-adult neurons using single-cell transcriptome
data (Darmanis et al., 2015) reveals completely unique gene sig-
natures that are deeply enriched for biological processes and
networks whose dysfunction leads to human nervous system
developmental disorders (full data access at https://toppcell.
cchmc.org/). We present these results to show the power of
this approach for any developing system.
What Cell Populations Are Present in and Distinguish
Pediatric Tissues?
For the largemajority of healthypediatric tissues, thereexists little
or no understanding of how cellular processes affect the course
of development andmaturation, or howpediatric cell populations
contrast with those from adults. Signaling, transcriptional, and
epigenetic factors are believed to act differently in children’s tis-
sues leading to a global state of growth-guiding development
(Stevens et al., 2013), while most adult tissues are believed to
be quiescent with respect to growth, and replication serves to
maintain established tissue architecture (Clevers and Watt,
2018). As a consequence, the cell types and their molecular
states contributing to tissue growth in children might well differ
from those during homeostatic cell renewal that serves to main-
tain a tissue in adult life, though specific concepts of ‘‘cell type’’
and ‘‘cell state’’ still require rigorous scientific definition (Trapnell,
2015) and ontological classification, such as that found in theCell
Ontology (Meehan et al., 2011; Osumi-Sutherland, 2017). Signif-
icant differences in cell populations between pediatric and adult
tissues have been observed, for instance, in bonemarrow (Chou-
merianou et al., 2010), but it is unclear if the observed differencesare a result of specific developmental cell states, unique pediatric
or adult cell types, or differences in tissue distribution or propor-
tion of cell populations, all of which may vary in tissues by age,
sex, genetics, or developmental stage. Cellular heterogeneity in
pediatric tissue cell populations may also contribute to the regu-
lation of growth while maintaining organ function. Regulatory
control may be due to changes in inter-cellular variability of
gene expression for key pathways or due to the action of rare
cell subpopulations that have not yet been discovered (Hase-
gawa et al., 2015), both of which would be impossible to resolve
with ensemble data generated from bulk tissue.
How Is Pediatric Physiology Distinguished in Health and
Disease?
The mantra that ‘‘children are not just small adults’’ is evident
from critical differences in pediatric pharmacology and physi-
ology as seen by responses to therapeutic interventions and
by treatment outcomes. These differences are not well under-
stood at the tissue level (Fernandez et al., 2011). Age-dependent
responses to anesthesia and medications (Batchelor and Mar-
riott, 2015; Andropoulos, 2018), environmental exposures
(Wright, 2017), traumatic injuries (Luerssen et al.,1988; Resch
et al., 2019), or surgical outcomes (Imura et al., 2001) have
been observed, but the reasons for these differences are still un-
clear. Childhood diseases also have age-dependent symptoms,
prognoses, and outcomes (Wheeler et al., 2011) even when
stratified for key clinical variables, possibly due to tissue devel-
opmental composition at the time of dysfunction (Mann et al.,
2010). Since many childhood-onset diseases become lifelong,
non-communicable chronic diseases, it is key to improve our un-
derstanding of disease inception in early childhood. Undetected
disorders in neonates, such as sudden infant death syndrome,
are restricted to a relatively small postnatal period during which
organs are undergoing rapidmaturation, and these disorders areDevelopmental Cell 49, April 8, 2019 13
Figure 3. Example of Data Reuse When Datasets Are Analyzed from the Perspective of Building the PCA
Reanalysis of the Human Brain Single-Cell Survey Study (Darmanis et al., 2015; NIH GEO GSE84465) yields a series of gene expression modules that exhibit the
greatest differential expression between cell classes, subclasses, and stages. The heatmap shows the top 200 differentially expressed genes per each cell type,
subtype, and stage (log2(TPM+1)) and highlights the the major signatures of fetal and postnatal neurons while contrasting the lack of representation of mature
differentiated neuron subtypes (cells on the right side of heatmap; signature modules on the lower half of heatmap) in fetal neurons (middle portion of the
heatmap). Very few of the top stage-specific neuronal genes overlap (fetal neurons versus postnatal neurons) despite enrichment of similar functions with
completely different genes comprising those categories. Moreover, there are also subtle, albeit fundamental, shifts in the biological functions of the develop-
mental stage gene modules. An interactive view of this data can be seen at http://toppcell.cchmc.org/.
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There is also little known about the effects of genomic variants,
environmental effectors, or their interactions on individual popu-
lations of cells within tissues and how these effects might vary by
age to alter normal development, cellular function, or therapeutic
efficacies in children.
Applications in Research and Medicine
The PCA component of the HCA would generate fundamental
contributions to our understanding of pediatric physiology in
health and disease and to the development of precise therapeu-
tic interventions for children. Below are some of the many poten-
tial applications to research and medicine.
Provide Age-Matched Single-Cell Profiles of Non-
Diseased Tissues as Reference Maps
Single-cell surveys of bioenergetics, growth, and functional pro-
grams from typical fetal and pediatric tissues will contribute to a
greater understanding of complex diseases arising from condi-14 Developmental Cell 49, April 8, 2019tions such as congenital birth defects, developmental delays,
inborn errors of metabolism, or pediatric cancer. As some pedi-
atric diseases differ in presentation and outcome by age, an atlas
of cells in healthy pediatric tissues organized by developmental
age would thus be an important and broadly useful data
resource. The PCAwould promote an ‘‘age and stage’’ approach
to sample ascertainment by supporting the creation of indexes
for coordinated tissue banks and study populations among
participating groups. Data from the PCA would be useful for
comparative analyses of normal tissue data versus that from
disease and dysregulated states in pediatric tissues, including
helping to identify suitable normal controls (Zeng et al., 2019)
as well as for concurrent studies on matched adult and develop-
mental tissues within the HCA’s Biological Networks. There is
increasing excitement about the use of stem-cell-derived ‘‘orga-
noids’’ as in vitro models of human organ development and
disease (Clevers, 2016). However, these cells and tissues repre-
sent early, usually fetal, stages of development and will require
Figure 4. Enrichment Analysis of the Major Signature Overexpressed in Fetal Neurons versus Those from Postnatal and Adult Human Brain
Modular analysis of data shown in Figure 3 yields functional associations (rectangles) shared by the top 200 contrasting genes (hexagons) and their links to Gene
Ontology, mouse gene knockout phenotype, or human OMIM gene-associated phenotype terms (phenotype-associated genes [yellow hexagons] which are
connected by separately colored edges per phenotype group. This example highlights the necessity of profiling fetal and pediatric cells and genes, which have
similar functions and processes compared to their adult counterparts but impact development, function, and physiology at different stages of development
through different gene and regulatory programs. It also indicates that critical genetic associations can only be fully appreciated in the context of fetal stage
neurons rather than their mature counterparts. Network analysis carried out using the ‘‘top 200 fetal quiescent neuron’’ gene-expression signature shown in
Figure 3 as analyzed using the http://toppcluster.cchmc.org/multiple-annotations biological network analysis functions to generate XGMMLoutput that was then
clustered in Cytoscape (Shannon et al., 2003).
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normal developing tissues to calibrate cellular fidelity.
Map Developmental Trajectories of Pediatric Cells and
Tissues
The PCA would make important contributions toward our under-
standing of human growth and development across the human
lifespan. ThePCAcould support generation and analyses of a vir-
tual ‘‘time course’’ ofmulti-omics data to provide insights into the
specifics of pediatric cell regulatory networks (Packer and Trap-
nell, 2018) across different developmental stages. For example,
predicted cellular trajectories in organs such as kidney during hu-
man fetal development suggest highly consistent developmental
programs in age-matched samples (Wanget al., 2018).Models of
cellular processes and their tissue locality would greatly enhance
our understanding of changing cellular composition during
normal and perturbed development. For instance, howpathways
and effectors are regulated within and across different children’s
tissues to promote healthy growth and development could be
extended to study these processes across the lifespan. Under-
standing these processes can help inform many aspects of
human biology and medicine, including wound healing, tissue
regeneration, and capacity to respond to physiological chal-
lenge. Comparisons of pediatric, adolescent, and adult single-cell data may also provide insight into how cell types transition
from ‘‘growing’’ to ‘‘adult homeostatic’’ states.
Contribute Insights into Public Health
Many chronic diseases that affect specific tissues, such as dia-
betes, asthma, and neuropsychiatric disorders, often first man-
ifest in childhood or adolescence. Environmental exposures
during development, the so-called exposome, may have long-
term effects on children’s and adult’s health and tissue function
at the cellular level (Balshaw et al., 2017; Vineis et al., 2017),
especially during specific developmental windows (Dietert
et al., 2000). Neuroimmunologic cell and tissue responses
to lower socioeconomic status, stress, inflammation, and air
pollution may be linked to observed health disparities (Olvera
Alvarez et al., 2018). Thus, targeted studies of single cells along
with genetic, demographic, socio-economic, and exposome
data may reveal biomarkers and therapeutic opportunities to
improve health and outcomes. Nutrition during childhood can
impact adult tissue development and function in clinically rele-
vant ways (Rytter et al., 2014) and may have long-term implica-
tions for public health (Eriksson et al., 2001; van Abeelen
et al., 2012; Lelijveld et al., 2016). A lifespan epidemiological
approach to studying human health (Ben-Shlomo and Kuh,
2002) would benefit from the PCA’s contributions to the spanDevelopmental Cell 49, April 8, 2019 15
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Perspectiveof normal tissue growth and cellular function on a stage-by-
stage basis.
Increase Precision in Pediatric Drug Discovery and
Toxicology
Children’s responses to medications can differ from those of
adults because of differences in drug metabolism and differ-
ences in cellular responses to drugs (Stephenson, 2005). These
differences can cause substantial morbidity, as was the case for
children with SHH-driven medulloblastoma who received vismo-
degib and subsequently suffered from irreversible growth plate
fusions (Robinson et al., 2017). The majority of pediatric patients
who require pharmaceutical treatment receive medications that
are either not approved or incompletely labeled for pediatric use
(Ward et al., 2018). The PCA would be particularly suited to help
address these disparities. Partnerships with the pharmaceutical
and biotech industries could help accelerate pediatric drug
development by providing an index of available pediatric tissues
and specialist researchers across participating institutions.
The PCA would also provide a pediatric tissue catalog reporting
on cell composition and genomic profiles organized by cell
type and developmental age. Single-cell data itself could
increase the precision of physiologically based pharmacokinetic
modeling for pediatric systems by deeply profiling tissue meta-
bolism and unique pathways that underlie developmental
programs in key pediatric tissues such as liver, kidney, and
gut. This may yield better predictions of adverse effects and pro-
vide insight into key differences in responses in pediatric clinical
trials and effectiveness studies compared to adults (Yellepeddi
et al., 2019).
Establish Linked Platforms for a Global Pediatric
Research Network
As a biological network within the HCA, the PCA will bring
together scientists across the pediatric research community to
enable, innovate, and accelerate research in single-cell-based
pediatric health and disease, which would otherwise be infea-
sible for individual laboratories or institutions to accomplish.
Data shared among global partners through the Data Coordina-
tion Platform (DCP) for the HCA will allow for novel and flexible
context-specific exploratory re-analyses that can yield entirely
new insights on molecular patterns and mechanisms respon-
sible for system-specific and multi-system growth and develop-
ment, as shown in Figures 3 and 4. Within the HCA, the PCA
will connect with complimentary organ-, tissue-, and system-
specific biological networks to relate pediatric and adult data.
Thus, partnerships across an international network of partici-
pating children’s hospitals, pediatric-focused research centers,
biorepositories, foundations, and consortia would be able to
accelerate pediatric research by helping to connect patients
and families to research efforts, source rare tissues, integrate
and disseminate novel platforms and approaches, develop and
support common data harmonization standards, and widely
share data to empower collaborative and diverse research
teams to address pressing basic and translational science prob-
lems. An existing collaborative endeavor among three of the
largest children’s hospitals in the country, The Genomics
Research and Innovation Network (GRIN), has already devel-
oped collaborative instruments and environments for pediatric
genetic and clinical data exchange and can be useful in
designing similar instruments for the PCA (GRIN, 2019). Mem-16 Developmental Cell 49, April 8, 2019bership in the PCA community is open to anyone willing to
commit to values of the HCA: transparency and open data
sharing; support of community, diversity, equity, and inclusion;
commitment to patient privacy; technology development for
preparing and analyzing pediatric samples; and dedication to
computational excellence (Regev et al., 2018). Information on
the effort is open to the community at the PCA component of
the HCA web site at http://www.humancellatlas.org/PCA and
members can register at https://www.humancellatlas.org/
joinHCA.
Expected Challenges and Timelines
Organization and Scope
Developing the PCA toward understanding human tissue growth
and development will require significant resources for profiling
and analyzing millions of cells from potentially thousands of tis-
sue samples from pediatric donors, with a focus on longitudinal
age. To ensure success, the broad scale of the endeavor out-
lined here would require contributions from diverse teams span-
ning clinical and basic research across multiple institutions,
which together enlist recruitment of samples spanning a range
of ages in many pediatric tissues. Legal, ethical, and resource
challenges would be encountered during establishment of a
PCA biological network that synergizes through collaboration,
freely and fairly shares data and best practices, and strives for
compliance reciprocity. An effective PCA, as part of the HCA,
would create new opportunities for tissue-specific sub-projects
to share and maximize resources, including expertise, work-
flows, and tools, while encouraging appropriate academic
attributions and output.
Representing PCA Data in the HCA Data Coordination
Platform
The HCA Data Coordination Platform supports ingestion of rich
and extensible metadata, cloud-scalable and multi-platform
mirrored data stores, cloud-native data processing pipelines
generating standardized and harmonized data, and user-friendly
data access for users. PCA data require specific metadata and
an emphasis on establishing data access patterns that accom-
modate data that is not openly consented. Pediatric research
may also emphasize experimental models that may motivate or
prioritize additional analysis elements under access control,
such as raw RNA-seq data and DNA-sequencing data for pro-
bands and families.
Ethics
The PCA must consider the ethics of obtaining samples from
healthy children who are not able to provide informed consent
themselves and releasing pediatric tissue data under informed
consent while simultaneously safeguarding patient identity.
The unique challenges of the PCA will be addressed by the
HCA Ethics Working Group to address frameworks on ethical
management and sharing of pediatric data and release recom-
mendations. Professional pediatric and genetics organizations
have recently offered input into ethical issues of genetic testing
and research in children (Botkin, 2016), but until recently, there
have been relatively few formal opinions on pediatric open-
data sharing. Recently, an interdisciplinary Paediatric Task
Team as part of the Global Alliance for Genomics and Health
(GA4GH; https://www.ga4gh.org/), has developed the Key
Implications for Data Sharing (KIDS) framework for pediatric
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part of the developing ethical framework.
Since children grow to be adults and may wish to withdraw
their samples at a later date, the PCA must also consider devel-
oping procedures for secure sample extraction and removal
while retaining strict privacy of pediatric samples for those
studies opting to restrict open-sample access. Privacy control
will be of particular importance to donor parents, who are often
very concerned about open-data sharing of their children’s
data and its future consequences (Burstein et al., 2014).
Additional protection of patient privacy through genetic de-iden-
tification could be accomplished by variant removal from raw
transcriptional data while keeping original data available in a
controlled-access repository with a Data Access Committee
(such as dbGAP or similar). The HCA Ethics Working Group
will continue to work with clinicians, researchers, and organiza-
tions to support ethical best practices while ensuring data will
have the greatest impact on science while respecting patient
privacy.
Technology
Single-cell profiling technologies are undergoing rapid evolution.
Both dissociation-based and in situ spatial assays are gaining
throughput. The molecular types potentially interrogated by
these assays include DNA, RNA, protein, metabolite, chromatin
spatial conformation, and epigenetic modifications (Stuart and
Satija, 2019). Moreover, to acquire a more complete picture of
gene activities in single cells, measurements of gene expression
should ultimately go beyond changes in overall levels and also
interrogate changes in gene isoforms arising from pervasive
alternative processing and modifications of RNA (Park et al.,
2018). Functional states of cells are also determined by their
constellation of protein abundances and by the myriad post-
translational modifications that regulate their associations and
activities. Single-cell proteome analysis is at an earlier phase
of development, mainly limited by losses associated with mate-
rial handling and chromatographic separations which adversely
impact the sensitivity and hence depth of analysis. Advances
in these areas along with continual rapid development of ever-
more sensitivemass spectrometrymethods show some promise
for this field (Stoeckius et al., 2017; DeLaney et al., 2018; Budnik
et al., 2018; Couvillion et al., 2019). Continued improvement
across all platforms has allowed for simultaneous ‘‘multi-omic’’
sampling from single cells (Kelsey et al., 2017; Macaulay et al.,
2017; Hu et al., 2018b; Clark et al., 2018; Stuart and Satija,
2019). The average costs of an experiment, although significant
at this moment, are expected to decrease over time as technol-
ogies are further developed and may also be decreased through
multiplexing strategies (Gehring et al., 2018; Regev et al., 2018;
Stoeckius et al., 2018).
Other rapidly evolving areas of research in the single-cell com-
munity include meta-scale approaches to information manage-
ment, for which the pediatric community must provide input as
necessary to their development. For instance, without attention
to age- and stage-specific pediatric anatomy, useful spatial at-
lassing of cells to their tissue and physical locations may be
impeded. Another important consideration for PCA projects,
where individual genetics and environmental exposures are
important variables, is ensuring the use of methods and strate-
gies to maintain the value of community investments by mini-mizing non-informative experimental replication and maximizing
cross-compatibility of data through validation and calibration of
new and enhanced technologies for both primary and secondary
data generation. Calibration standards between studies and
platforms and technology groups will allow for compatibility
and linkage between older standards and evolving technological
platforms. As part of the HCA, the PCA will reuse other HCA
protocols for pediatric tissues as appropriate and follow the
guidelines provided by the HCA Standards and Technology
Working Group.
Sample Ascertainment, Biopsy, and Management
Collaborative biological PCA networks across various institu-
tions will need to define strategies for tissue procurement, pres-
ervation, and single-cell sample preparation while maintaining
assay fidelity and throughput. Obtaining pediatric samples is
non-trivial but regularly accomplished in studies and clinical tri-
als. Approaches to obtaining pediatric samples have been
described across many studies, utilizing tissues from surgical
biopsy, transplantation byproducts, and parental donations
following accidents (Bandyopadhyay et al., 2018). Methods for
easily identifying available pediatric tissues from PCA collabora-
tors with attention to inclusion of demographic diversity, such as
sex and ethnicity, will be a critical component of the PCA’s bio-
banking efforts.
While protocols for single-cell analysis suggest processing
either newly acquired or cryopreserved tissues, there have
been advances in processing single-cell DNA from formalin-
fixed paraffin-embedded tissues to study whole-genome copy
number variation in cancer (Martelotto et al., 2017), as well as
recovery of transcriptomic data from cryopreserved tissues
(Konnikova et al., 2018), both of which open up opportunities
for similar analyses utilizing samples from pediatric tissue repos-
itories. The PCA could assist projects by linking them to other
well-established biobanks such as those founded by the Chil-
dren’s Oncology Group (https://www.childrensoncologygroup.
org/), the Children’s Brain Tumor Tissue Consortium (https://
cbttc.org/), and Alex’s Lemonade Stand (http://www.cccells.
org/).
Computation and Information Management
Like other HCA projects and biological networks, the computa-
tional challenges of the PCA are a critical consideration. New,
improved protocols for tissue preparation, cell isolation, and
computational analysis contribute to the growing size and
complexity of single-cell data sets (Svensson et al., 2018), an
example of which is the HCA’s recent release of transcriptome
data for approximately 530,000 cells from umbilical cord blood
and bone marrow (https://preview.data.humancellatlas.org/).
To standardize our approach and allow for comparison with
adult components of the HCA, the PCA will leverage the
HCA’s DCP, designed to harmonize deposited data and
provide data and portals for access, analysis tools, and
visualization. A key analytical need for the PCA, analyses of
longitudinal datasets, would be driven by PCA researcher
needs. Computational methods with the ability to cluster and
visualize cellular heterogeneity across millions of cells have
been recently introduced (Cho et al., 2018; Wolf et al., 2018;
Zhang and Taylor, 2018), which could be adapted for longi-
tudinal data, for instance using machine learning approaches
(Hu and Greene, 2018; van Dijk et al., 2018; Lin et al., 2017;Developmental Cell 49, April 8, 2019 17
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cell lineages and trajectories particular to pediatric devel-
opment.
Data Standardization, Harmonization, and Reuse
In-depth anatomical knowledge of how individual cells relate to
tissues, organs, and organismal development has been encoded
using the Uberon anatomy and stage ontologies, which relate
anatomical entities at all spatio-temporal scales to develop-
mental stages. A PCA tissue map that supports ‘‘age and stage’’
requires novel approaches that can combine spatiotemporal
classification of cellular attributes in a ‘‘bottom-up’’ fashion
with existing ‘‘top-down’’ anatomical and developmental knowl-
edge. Exploratory data analysis of highly complex PCA data will
be critical for generating novel hypotheses on growth and devel-
opment in pediatric tissues. Traditional models for cellular clas-
sification during development need to work harmoniously with
omics-based single-cell classification strategies in order to
maximize utility across the broadest set of scientific use
cases aimed at understanding development and pediatric dis-
ease progression (Aevermann et al., 2018; Osumi-Sutherland,
2017). Despite the rich resources provided by theGeneOntology
and Cell Ontology to record cellular and subcellular gene
functions, much work remains in defining and linking across
new and existing ontological terms and frameworks on normal
and abnormal development, gene function, cell type, and cell
state (Gene Ontology Consortium, 2017). The PCA will work
with the HCA’s metadata team to ensure that the HCA metadata
schema in the DCP reflects the richness of pediatric-specific
metadata.
Funding and Resources
The opportunity to contrast children’s tissues at a single-cell
level across ages would provide a unique and unprecedented
window into pediatric diseases and their treatment. The PCA
represents a project with challenges in tissue procurement and
single-cell preparation but offers significant rewards in the po-
tential contributions to our understanding of children’s health
and disease. As a diverse and interdisciplinary effort, the PCA
would benefit from programs such as the NIH Common Fund
or the recently formed trans-NIH Pediatric Research Consortium
(N-PeRC), which was founded to coordinate pediatric research
programs across NIH’s 27 institutes and centers. It is expected
that some fundraising efforts will often be specific to partici-
pating institutions or groups and not PCA-wide, as has been
the case across the HCA.
Pilot Organ Systems
There exist a substantial number of tissues and organs poised for
exploration by a coordinated PCA, eachwith significant opportu-
nity for producing new insights along with translational and
clinical promise. While the PCA pilot studies should focus on
normal (non-diseased) tissue, this list is not intended to be
exhaustive or directive for all possible tissue, organ, and dis-
ease-oriented atlases.
Brain and Nervous System
Recent studies of CNS development are richly implicative of the
roles of genomic maturation — transcriptomic and epigenetic —
of neuron, astrocyte, oligodendrocyte, microglial, and endothe-
lial lineages. Tissue-level processes such as synaptogenesis,
myelination, and pruning start during gestation and continue18 Developmental Cell 49, April 8, 2019through to adulthood (Emery, and Lu, 2015; Sharma et al.,
2016). Cellular models of neuronal development used for spatio-
temporal reasoning and classification will require reconciliation
with molecular characterization (Osumi-Sutherland et al.,
2012). Moreover, given that known genetic and non-genetic
risk factors only explain a fraction of overall disease risk (Manolio
et al., 2009), genomic variability between individual neurons of
the brain has long been suspected to contribute to the diversifi-
cation of neuronal complexity and possibly the burden of neuro-
logical disease (Muotri and Gage, 2006; D’Gama and Walsh,
2018). Molecular characterization of cell types in the developing
human brain has recently begun and has already led to the iden-
tification of novel cell types, novel cell-type-specific markers,
and insight into gene networks enriched in specific cells (Pollen
et al., 2015; Thomsen et al., 2016; La Manno et al., 2016; Now-
akowski et al., 2017). As of now, there have been few deep mo-
lecular characterizations of cell types in the pediatric brain as
compared to adult, including in critical neurological and brain
anatomical locations (Lake et al., 2018), such that hypotheses
linking children’s neurological health and disease to cell types
and cell states remain limited by our lack of foundational
knowledge.
Single-cell DNA sequencing of the human cortex has been
used to follow a neuron’s developmental lineage, through tracing
mutational patterns (Lodato et al., 2015) or using pseudotime
methods (Zhong et al., 2018). These methods could help to
reveal developmental lineages and anatomic complexities in
the brain with respect to organogenesis, maturation, and the
attainment of a fully functional central nervous system.
For the field of neurology, mapping neuronal lineage and as-
sessing the variability within the genetic and epigenetic land-
scape will be relevant for progress in common neurological
disorders in children such as epilepsy, autism, and develop-
mental delay. For example, studies into somatic mosaicism —
which is increasingly recognized as a source for focal epilepsies
and brain malformations — led to the discovery of the mTOR
pathway as a crucial mechanism for epilepsies (Lee et al.,
2012; Mirzaa et al., 2016; Alcantara et al., 2017; Lim et al.,
2017a). In addition, somatic brain mutations unrelated to the
mTOR pathway have also recently been discovered in lesional
and non-lesional epilepsy, illustrating the potential power of a
PCA for characterizing previously opaque brain disorders
through sequencing (Winawer et al., 2018). In patients with
autism, postzygotic mutations, only affecting a subset of cells,
are increasingly recognized as a disease mechanism (Lim
et al., 2017b). In addition, the cellular architecture of human
neurons may have unique features, such as human-specific
interneuron subtypes (DeFelipe et al., 2006; Boldog et al.,
2018), suggesting that elucidating the genetic and epigenetic
variability in the human brain through a PCA may discover previ-
ously unrecognized cellular patterns that are unique to the devel-
oping human brain.
Cell signaling in the neural stem cells, such as the Notch
pathway, can be detected in pediatric brain tumors (Lasky and
Wu, 2005) and single-cell RNA sequencing of developing
human cortex has revealed a diversity of neural stem and pro-
genitor cells with potential roles in neurodevelopmental diseases
(Nowakowski et al., 2017). In the field of neuro-oncology, pediat-
ric CNS cancers arise in distinct neuroanatomical locations,
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ciated with lineage-specific developmental transitions. Profiles
of normal brain tissue and of neural stem cells by age as provided
by the PCA is necessary in order to develop hypotheses as to cell
types and processes giving rise to CNS tumors and the associ-
ated risks involved (Gage and Temple, 2013).
Gut
The normal human gut manages fluid, electrolyte, and nutrient
absorption needed for survival while protecting us from intestinal
microbes. Cells performing these tasks include epithelial
absorptive cells, mucus-producing cells, stem cells, transit
amplifying cells, Paneth cells, enteroendocrine cells, endothelial
cells, fibroblasts, smooth muscle cells, intestinal pacemaker
cells, enteric neurons, enteric glia, and a wide array of immune
system cells in the bowel wall (Smillie et al., 2018; Haber et al.,
2017). Some of these cell types can be further subdivided. For
example, there are at least 10 types of enteroendocrine cells
that sense luminal contents and mechanical distension and
then secrete a wide array of hormones and cytokines that impact
bowel epithelial function, motility, mucosal immunology, pancre-
atic endocrine and exocrine function, gallbladder contractility,
and appetite (Worthington et al., 2018; Psichas et al., 2015).
The enteric nervous system contains about as many neurons
as the spinal cord, and there are dozens of neuronal and glial
cell types that control motility, regulate blood flow, and impact
immune and epithelial cell function (Furness, 2012). Intestinal ab-
sorption, patterns of motility, bowel movement frequency, and
susceptibility to intestinal injury all change as children grow in
response to microbes, nutrients, and genetic programming, so
PCA data for the bowel will illuminate many aspects of human
health. For example, late fetal bowel is particularly susceptible
to serious inflammation called necrotizing enterocolitis (NEC), a
problem that does not occur in term infants, older children, or
adults (Nin˜o et al., 2016). NEC susceptibility is presumed to
reflect age-dependent changes in intestinal barrier function,
bowel motility, and immune system function that may be re-
flected in changes in cell populations as well as single-cell
gene expression patterns at various ages. In the first 5 years of
a child’s life, the bowel changes dynamically with the length of
the small and large intestine nearly doubling during this interval
(Struijs et al., 2009). Remarkably, individual cells must maintain
regional identity in this dynamically growing organ because pat-
terns of bowel motility and epithelial function differ markedly
along the bowel length. Intestinal microbiota changes dramati-
cally in the first 3 years of life, in part because of diet changes
but also because of changes in immune and epithelial cell func-
tion. In contrast, intestinal microbiota is relatively stable during
adulthood (Yatsunenko et al., 2012). These differences are
important because the composition of the gut microbiome has
been shown to significantly impact health. Supporting the hy-
pothesis that critical changes occur during late fetal and post-
natal stages, a recent single-cell study on human fetal intestine
revealed over 30 cell types and demonstrated important differ-
ences between fetal and adult intestine (Gao et al., 2018).
Defining what is normal in varied bowel regions at distinct
pediatric ages is essential, especially as we consider disease
processes unique to the pediatric age group including congenital
anomalies, metabolic and mitochondrial diseases, and single-
gene defects that cause bowel dysfunction.As another example where PCA data for the bowel will be valu-
able, chronic disruption in the gut’s cellular function and compo-
sition can lead to very early onset and pediatric inflammatory
bowel disease (IBD). IBD affects over 80,000 American children.
It manifests before 18 years of age in 25% of the 2 million
affected Americans (Loftus, 2003), and the disease is increasing
most rapidly in very young children less than 6 years of age
(Benchimol et al., 2017). The specifics of the tissue environment
and the genetic origins of IBD vary between individuals, with
many identified genetic variants that result in disease develop-
ment by altering the intestinal barrier or immune cell function
causing hyperimmunity, autoimmunity, or immunodeficiency
(Peloquin et al., 2016; Jostins et al., 2012). The phenotype of
pediatric IBD can be different, (Billiet, and Vermeire, 2015) and
more severe (Rosen et al., 2015), as compared to older patients.
There can also be differences in patterns of bowel motility
(Chumpitazi, and Nurko, 2008). The immune system may play
a more prominent role in pediatric IBD, particularly in children
with the disease, as the immune system develops in the first
3 years of life (Simon et al., 2015). The Gut Cell Atlas program
supported by theHelmsley Charitable Trust will focus on such ef-
forts (Helmsley Trust, 2018).
Collectively, these observations suggest a critical need to ac-
quire pediatric bowel data (e.g., pooled and single-cell RNA
sequencing, metabolomic data, proteomic data, and information
about cellular organization) for a wide array of intestinal cell
types, at varied ages, and in many bowel regions. The PCA
can provide these critical data about cell populations using
mucosal biopsies and surgically resected tissue from healthy
(e.g., organ donor) and diseased children (e.g., inflammatory
bowel disease and Hirschsprung disease resection specimens).
Comparisons between PCA and adult HCA data will provide
valuable insight as we develop new approaches to rebuild and
repair damaged gut epithelium and establish innovative treat-
ment strategies for intestinal diseases. PCA data will also facili-
tate generation of new organs from stem cells to replace or repair
injured bowel.
Heart
The heart undergoes a period of postnatal remodeling involving
significant gene splicing and expression changes that are
distinct from those in adults (Xu et al., 2005). In children, congen-
ital heart disease (CHD) makes up nearly one-third of all major
congenital anomalies, with an occurrence of 8 out of 1,000 live
births (van der Linde et al., 2011), and although significant prog-
ress has been made in understanding genetic contributions to
CHD (Jin et al., 2017), it is not yet well understood how abnormal
tissue development leads to CHD. The vital function of the heart
has been known for hundreds of years, but the molecular and
cellular underpinnings of postnatal heart maturation and function
remain poorly understood. Hearts of different pediatric stages
exhibit significant anatomical, genetic, and functional heteroge-
neity. Cell-type composition and metabolic states in the heart
undergo significant changes and remodeling for functional
maturation during the whole pediatric period. Single-nucleus
RNA-seq of nearly 20,000 nuclei has been used to study different
postnatal developmental stages of the mouse heart, which has
revealed major and rare cardiac cell types as well as significant
anatomical and functional heterogeneity among all cell types in
the postnatal developing heart (Hu et al., 2018a; DeLaughterDevelopmental Cell 49, April 8, 2019 19
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atric mitochondrial cardiomyopathy, profound cell-type-specific
modifications of the cardiac transcriptome were revealed at sin-
gle-cell resolution, including changes of subtype composition,
maturation states, and functional remodeling of each cell type
(Hu et al., 2018a). Similar experimental approaches can also
be applied to studying the pediatric heart. A PCA of the heart
can fill these knowledge gaps and bring novel insights into
many pediatric heart diseases that affect tens of thousands of
children each year.
Hematopoietic and Immune Systems
Immune homeostasis has been shown to shift dramatically as
children lose maternally transferred antibodies, acquire new in-
fections and antigenic exposures, and experience changes in
microbiota over time (Putignani et al., 2014; Kollmann et al.,
2017; Olin et al., 2018). The hematopoietic and immune system
undergo remarkable changes in the first years of a child’s life,
with profound impact on health throughout the rest of the life-
span. Children are born with a relatively naive T/B cell compart-
ment, hypofunctional innate immunity (Collins et al., 2018), and
fetal red blood cells. Intrinsic developmental gene expression
programs and extrinsic environmental influences over the
following years shape the developing hematopoietic system
(Schatorje´ et al., 2011; Belkaid and Hand, 2014). Perturbed
development of immune competence and tolerance has been
linked to allergies, atopic disease, autoimmune disease, cancer,
andmetabolic diseases (Renz et al., 2017), accounting for a large
burden of human morbidity and health spending. Vaccination,
our primary effort to modify immunity throughout the world, is
almost exclusively performed in the young child and in early
adolescence (Levy et al., 2013). The neonatal, pediatric and adult
immune systems respond very differently to infection, trauma,
and other inflammatory insults (Maddux, and Douglas, 2015;
Beura et al., 2016); therefore, it is critical to define and under-
stand the shifting pediatric hematopoietic system separately
from that of adults.
Recently, single-cell transcriptomic studies of the adult he-
matopoietic and immune systems (reviewed in Papalexi and Sat-
ija, 2018) have provided new insights into the immune system,
including leukocyte developmental and differentiation hierar-
chies in the bone marrow (Velten et al., 2017), the effect of mye-
lodysplastic clones on normal hematopoiesis, and the specificity
and functional response to infection and antigenic challenges
(Stubbington et al., 2017; Villani et al., 2017). A recent unbiased
transcriptomic survey of over 100,000 hematopoietic bone
marrow cells from eight healthy adults revealed significant varia-
tion in the relative proportion of distinct cell lineage between
donors as well as lineage-dependent gene expression with
donor age (Hay et al., 2018). Another study on bone marrow
included a sample from a single child who had a remarkably
different distribution of transcriptionally defined stem and pro-
genitor populations compared to the adult samples, making a
strong case for the necessity of a pediatric-specific immune
cell atlas (Zhao et al., 2017). The HCA preview data include
cord blood samples from multiple individuals, showing substan-
tial variation (https://preview.data.humancellatlas.org/).
Understanding normal pediatric hematopoietic and immune
development would thus have critical impact on child and adult
health. Pediatric leukemia is the most common pediatric cancer20 Developmental Cell 49, April 8, 2019and can have an age-dependent prognosis, perhaps linked to
the immune system’s development in ways that are not yet un-
derstood. While the field of hematopoiesis has learned from
the study of model organisms such as mice, many of the devel-
opmental dependencies discussed above are specific to hu-
mans and cannot be modeled or understood without looking at
the human pediatric hematopoietic and immune system as it
matures. The pediatric immune atlas will sample from primary
(bone marrow, thymus) and secondary (lymphatic fluid, tonsil,
peripheral blood, and in rare cases, spleen) lymphoid tissues,
as well as immune cells obtained from tissues such as lung, liver,
intestine, and skin, across a wide range of ethnic backgrounds
and ages including newborns and preterm infants.
Kidney
The kidneys receive 20% of the heart’s blood output and in
adults generate approximately 180 liters of glomerular filtrate
per day. In mammals, the normal kidney forms from a lineage-
specific set of progenitor cells that finish differentiating soon
after birth (Lindstro¨m et al., 2018). There is considerable individ-
ual variation in the number of nephrons per kidney, with impor-
tant medical consequences (Bertram et al., 2011). The basis
for this variation is not understood. Children can suffer a number
of kidney diseases including structural malformations, glomeru-
lonephritis, and focal segmental glomerulosclerosis (FSGS)
(Harambat et al., 2012). FSGS, themost common glomerular dis-
ease in pediatric patients, is poorly understood, progressive,
challenging to treat, and the risk of recurrence in transplanted
kidneys can be as high as 30%–40% (Kiffel et al., 2011). Com-
parison of the cellular composition of primary and recurrent
FSGS kidneys with normal age-matched kidney tissue may
help contrast the cell-level pathophysiological processes
operating in FSGS. The PCA would contribute to our under-
standing of the normal and abnormal development of the
human kidney by providing samples of cell types and population
distributions from normal fetal and early neonatal tissues. The
PCA would also work in a synergistic and complementary
fashion with the Kidney Precision Medicine Initiative (https://
kpmp.org/), which aims to provision deep classification of adult
kidney disease patients and their cellular attributes in a kidney
tissue atlas.
Liver
The liver is the largest solid organ in the body, critical for
metabolic function. For children with end-stage liver disease,
transplantation is often the only option. 33% of pediatric liver
transplantations in North America from 1995-2002 were per-
formed on children less than 1 year of age (McDiarmid et al.,
2004). Biliary atresia (BA), a progressive fibrosing cholangiop-
athy presenting in infancy, is the leading indication for liver trans-
plantation in children (Asai et al., 2015; Verkade et al., 2016).
Recent studies have shown that damage to bile ducts in BA
begins at or before birth (Harpavat et al., 2011). A detailed map
of gene expression in infant bile ducts, which continue to
develop in the weeks and months postnatally, could shed light
on the pathogenesis of BA and other developmental disorders
of bile ducts presenting during childhood. Targeted interventions
to prevent the development and progression of end-stage liver
disease in children will require a detailed understanding of the
cellular components of the normal pediatric liver. Recently, a
map of the adult human liver, as identified by single-cell RNA
Developmental Cell
Perspectivesequencing revealed distinct liver resident macrophages in the
human liver, with inflammatory and non-inflammatory properties
(MacParland et al., 2018). The rationale for developing a pediat-
ric-specific liver map lies in the fact that there are differences in
metabolic functions in the pediatric and adult liver although the
mechanisms are unclear (Blanco et al., 2000). Drug metabolism
differs substantially in infants and children as compared with
adults (Stephenson, 2005); a map of gene expression in hepato-
cytes in the infant liver would provide detailed information about
the timeline for hepatocytematuration during early development.
Moreover, there are specific liver diseases that are found in
adults, for example, non-alcoholic fatty liver disease (NAFLD),
that can have a unique histological presentation in children
(Schwimmer et al., 2005), possibly suggesting distinct underlying
dysfunctions are promoting disease in children. A baseline map
of the healthy pediatric liver will help in the identification of path-
ological cellular processes driving the development and pro-
gression of pediatric liver diseases leading to liver failure.
Lung
The human lung is a wonderfully complicated organ required
for the transition to air breathing at birth and for ventilation
throughout our lifetime. Moreover, the lung constitutes a primary
interface with the environment, generating innate and adaptive
immune responses to danger signals. Lung function is inherently
linked to its remarkable tubular-alveolar structure of the airways
and the lung parenchyma and dependent upon the contributions
and interactions among a great diversity of cells and the matrix
scaffolds that support them. During lung morphogenesis and
until maturity, cells proliferate, migrate, differentiate, and interact
to form and maintain lung architecture (Hogan et al., 2014). A
diversity of mesenchymal, epithelial, endothelial, vascular,
neuronal, and hematopoietic immune cells are present in precise
numbers and stereotyped locations, interacting to maintain tis-
sue homeostasis and regeneration after injury. The lung is vulner-
able to environmental challenges, being directly exposed to
inhaled gases, particles, toxins, and microbial pathogens that
underlie the pathogenesis of acute and common chronic lung
disorders affecting children. Many of these disorders have life-
long health consequences. Respiratory Distress Syndrome and
Bronchopulmonary Dysplasia are relatively common disorders
affecting newborns and preterm infants (Reuter et al., 2014).
Chronic disorders of mucociliary clearance and host defense,
for example, cystic fibrosis and primary ciliary dyskinesia, are
associated with chronic inflammation, infection, and tissue re-
modeling with lifelong consequences. Reduced lung growth dur-
ing pediatric development, such as observed in children with
asthma, may even predispose to chronic obstructive pulmonary
disease (COPD) later in life (McGeachie et al., 2016). Asthma and
COPD are chronic inflammatory lung diseases that arise from the
interaction of a genetic predisposition to develop the disease
with specific environmental factors that trigger disease incep-
tion. While asthma typically starts in the first few years of life
(Holt and Sly, 2012), most asthma studies, including the first
single-cell analyses (Vieira Braga et al., 2019), study the chronic
phase of the disease, thereby potentially missing crucial causa-
tive mechanism operating in children developing the disease.
Also for COPD, where expression of the disease is generally
only observed after the age of 40 (Rabe and Watz, 2017), under-
standing the cellular mechanisms governing lung growth duringpediatric development is of critical importance to be able to
design novel interventions aimed at lung repair.
The roles of multiple cell types and their interactions in normal
and diseased lung can be explored by single-cell analytic ap-
proaches. For example, single-cell RNA profiling of human
epithelial cells has provided insights into the pathogenesis of
pulmonary fibrosis, cystic fibrosis, and asthma (Xu et al., 2016;
Montoro et al., 2018; Reyfman et al., 2018; Vieira Braga et al.,
2019). Atypical non-lineage restricted epithelial cells were
identified that contribute to tissue remodeling in idiopathic
pulmonary fibrosis. Likewise, a new epithelial cell type, the iono-
cyte, which expresses CFTR, was identified by single-cell
sequencing, supporting its role in the pathogenesis of cystic
fibrosis (Montoro et al., 2018; Plasschaert et al., 2018).
One notable reference atlas project, funded by the National
Heart, Lung, and Blood Institute (NHLBI), LungMAP (LungMap,
2019) has provided detailed molecular portraits of distal lung
cell class and subclasses of the mouse and is beginning to cover
proximal bronchial and human samples (https://www.lungmap.
net/about/lungmap-team/nhlbi). Data from the efforts thus far
includes more than 40,000 single cells from developing and
postnatal stages as well as bulk cell profiles of mRNA, miR, pro-
teins, lipids, metabolites, and epigenomic profiling (Ardini-Pole-
ske et al., 2017; Du et al., 2017). An initial analysis of neonatal and
pediatric human lung samples has also begun (Bandyopadhyay
et al., 2018), with key initial goals of providing profiles of sorted
cell types, via mRNA, protein, lipid, metabolite, and epigenomic
measures and technologies representing key goals. Micro- and
macro-2D and micro- and macro-3D imaging modalities are
also part of the overall effort with goals that include developing
integrative models of cell and tissue morphogenesis, signaling
networks, andmulti-scale physiology, to understand lung forma-
tion, maturation, function, injury, and repair (Xi et al., 2017; Zach-
arias et al., 2018). Substantial differences of cell-type-specific
signatures between embryonic, fetal, and postnatal cell types
occur that demonstrate a high degree of lineage specialization
reflective of different transcription factor drivers and important
developmental pathways that are not shown in corresponding
cell types of postnatal lung (Treutlein et al., 2014; Ding et al.,
2018). The ability to accurately analyze large numbers of cells
by single-nuclear RNA sequencing, chromatin accessibility,
and high-resolution imagingwill enable the use of human tissues,
including our archival tissues from children with rare lung dis-
eases, to identify the cells, genes, and gene networks involved
in the pathogenesis of acute and chronic lung diseases.
Placenta
The placenta is a unique temporary organ, which acts as lungs,
liver, gut, kidneys, and endocrine glands for the fetus, supplying
it with nutrients and oxygen, and harmonizes the cross-talk be-
tween the fetal and maternal immune system (Burton, and Fow-
den, 2015). The structure of the maternal-fetal interface features
a complex relationship between fetal cells and maternal tissue.
Specifically, fetal trophoblasts invade into the maternal decidua,
orchestrated by maternal immune cells, stromal cells, and glan-
dular epithelial cells. While it is essential for intrauterine fetal
growth and development, it also plays a major role in perinatal
and pediatric health outcomes. Dysfunction at the maternal-fetal
interface can have significant health implications to mothers and
offspring, such as increased risk of cardiovascular disease inDevelopmental Cell 49, April 8, 2019 21
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et al., 2008; Seely et al., 2015), or increased risk of type 2 dia-
betes in the offspring during late adult life (Kajantie et al.,
2017). One such dysfunction is preeclampsia, a syndrome man-
ifested by a sudden increase in blood pressure and accompa-
nied by proteinuria or in association with thrombocytopenia,
impaired liver function, development of renal insufficiency, pul-
monary edema, or new-onset cerebral or visual disturbances
(American College of Obstetricians and Gynecologists et al.,
2013). It affects 7%–10% of pregnancies worldwide and is the
leading cause of maternal and fetal morbidity and mortality.
The cause of preeclampsia, effective treatment, and reliable
onset prediction are still unknown; however, it is evident that
the placenta plays amajor role in the development of this disease
(Huppertz, 2008). Furthermore, disruption of the fine balanced
cross-talk between immune cells and trophoblast early in
pregnancy might cause abnormal placentation leading to faulty
placental perfusion and disturbed fetal nutrition (Hiby et al.,
2010; Przybyl et al., 2016). The effect of preeclampsia on a child
requires more attention in order to minimize risks in adulthood.
For example, Reveret et al. reported an immediate impact of pre-
eclampsia on the children’s blood pressure, measured within
days of birth, necessitating long-term cardiovascular follow-up
and targeted preventive strategies for affected offspring (Reveret
et al., 2015). The statement that child health starts from the
placenta would not be an exaggeration, but the details of that de-
pendency are not well understood.
Studies featuring placental tissues at single-cell resolution
have been recently published in mouse (Nelson et al., 2016)
and human (Pavlicev et al., 2017). They revealed the cell commu-
nication network together with functionally distinct cell types of
the maternal-fetal interface at term; used transcriptomic infor-
mation derived from single cells for the interpretation of cell-
free plasma RNA, thus opening new possibilities for non-invasive
diagnostics (Tsang et al., 2017); and described human tropho-
blast differentiation. These results advanced our understanding
of human placentation as well as the stark differences between
rodent and human (Liu et al., 2018). Reproductive success is
dependent on the maternal-fetal interface in the first weeks of
pregnancy (Smith, 2010). Recently, a comprehensive single-
cell map of first-trimester maternal-fetal interface has revealed
novel subsets of maternal and fetal cells and their crucial tolero-
genic role in this environment (Vento-Tormo et al., 2018). The
PCA will focus on expanding this knowledge in healthy tissues
to help inform later work targeting diseases of pregnancy,
which account for the large proportion of child health com-
plications. Since the placenta undergoes major molecular,
structural, and functional rearrangements during three trimes-
ters, the PCA would work with the greater HCA community
to perform a fine-grain map of all stages of placenta develop-
ment. One of themajor implications of the placenta PCA subproj-
ect would be improved cell-type profiles and interpretation of
their interactions, which are important not only for future
placenta single-cell studies but also for re-annotating accumu-
lated bulk RNA-seq data, introducing an added value to the
whole project.
Skeletal Muscle
At over a third of the human body weight, skeletal muscle is not
just the single largest tissue in the human body, but it also con-22 Developmental Cell 49, April 8, 2019tributes the most to metabolic and physical health by regulating
energy usage, storage, production, and regulation of body tem-
perature to name just a few of its functions (Zurlo et al., 1990;
Rowland et al., 2015). While skeletal muscle is home to a variety
of cell types, its minimum functional unit is the multinucleated
syncytial cell called the myofiber. This mesodermal cell lineage
is formed by the fusion of mono-nucleated precursors called
myoblasts, derived primarily from satellite cells. The myogenic
process begins early during human growth by a developmental
program that leads to the addition of nuclei to the growing mus-
cle fiber, and it is followed by the growth of the muscle fibers to
its optimized size based on the extent of use (or disuse) of the in-
dividual muscle. While the satellite cells remain quiescent during
adult life and much of the muscle activity maintains status quo,
the muscle maintains the full capacity to grow and regenerate
in response to stress, trauma, or disease that damages the my-
ofibers (Lepper et al., 2011; Sambasivan et al., 2011). Thus, the
cellular composition and the expressome of skeletal muscle
changes from early development and growth to a homeostatic
state during adulthood while, at all times, maintaining its ability
to efficiently respond to changes that may impinge upon it. The
knowledge of these skeletal muscle abilities has come from
the cellular, molecular, and genetic analysis of cultured satellite
cells and a variety of model organisms including C. elegans,
D. melanogaster, D. rerio, and M. musculus. Such analyses
have identified a wide array of myogenic regulatory factors and
cell types that contribute to the process of developmental or
regenerative myogenesis. Single-cell RNA analyses have been
performed on adult satellite cell and non-myogenic cells isolated
frommice and humans (Cho and Doles, 2017; Tabula Muris Con-
sortium et al., 2018; Giordani et al., 2018; Heuvel et al., 2018).
While offering some insights into the molecular complexity and
diversity, it does not include the multi-nuclear myofibers respon-
sible for the majority of muscle function. In contrast, single-nu-
cleus sequencing has only been performed on human myotubes
(Zeng et al., 2016), which supports the use of single nuclear
extraction, sequencing, and analysis in skeletal muscle tissue.
Furthermore, with myofibers being the minimal functional entity
of muscle use, disuse, damage, or regeneration, there is a press-
ing need to understand the genetic diversity of the myofibers.
This diversity likely exists between the nuclei of different types
of the myofibers (e.g., slow- and fast-twitch muscle fibers) and
also perhaps among the multiple nuclei that populate individual
myofibers, as reported by cultured cell analysis (Zeng et al.,
2016). Little attention has also been focused on analyzing the
developing muscle, which is of greater relevance to the pediatric
population. In addition, the puzzling facts that muscles at
different anatomical locations are differentially affected in in-
herited muscular dystrophies may be explained by intrinsic dif-
ferences in the muscle cells. The PCA effort is required to
develop an atlas of such single-cell profiles for mono-nucleated
cells in human muscle as well as single-nucleus RNA profiles for
human myofibers during development. Such information will be
indispensable for understanding how the molecular program of
developing muscle allows for the balancing act required to
maintain the terminally differentiated status of the muscle while
having the capacity to regenerate fully. Disruptions in this
balancing act have been identified in congenital and degenera-
tive skeletal muscle disorders. Analyses of normal healthy
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for this process and support the ongoing efforts in developing
treatments that restore the balance lost in diseased muscle
due in genetic and other diseases.
Skin
As one of the most accessible human organs, skin provides the
perfect system to obtain tissue to understand the changes and
specialization of single cells and how they vary over age from
prematurity through adolescence, from multiple sites on the
body, over multiple ethnic backgrounds, and between sexes.
Skin plays six primary functions: protection, absorption, excre-
tion, secretion, regulation, and sensation (Proksch et al., 2008).
The outermost layer of the skin, the epidermis, is composed of
multiple cell types including keratinocytes, melanocytes, Lang-
erhans cells, mast cells, and Merkel cells (Matsui, and Amagai,
2015), and below that, the dermis is made of fibroblasts which
secrete the connective tissue matrix and is a home for nerve
and endothelial cells. The composition of these layers changes
significantly from infancy to adulthood in terms of cell distribu-
tion, connective density, caliber and distribution of hair follicles,
and number and location of apocrine and sebaceous glands as
well as in inherent elasticity and ability to remodel. Children
with rare disorders like ichthyosis and epidermolysis bullosa
have provided insight into the careful interplay of cells, lipids,
collagen, and proteins needed to provide the barrier function
and strength of the skin (Matsui, and Amagai, 2015).
The human skin has been profiled in the Human Protein Atlas
where tissue sections for histology and tissue cDNAs formicroar-
rayswereused toexploreproteins expressed in the skin, follicular
units, sweat glands, and sebaceous glands (Uhle´n et al., 2015).
Through this project, over 400 genes have been shown to be
highly enriched in the skin compared to other organs. In-depth
analysis of the elevated genes using antibody-based protein
profiling allowedcreationof aportrait of in-situprotein expression
for the different layers of the epidermis and in the dermis (Edqvist
et al., 2015). Despite these advances, proteomic and expression
analysis of normal skin tissue from multiple sites on the human
body from infancy through adolescence has not been performed
in a systematic way and is critical for understanding develop-
mental changes in pigmentation, skin regeneration, hair cycle,
and connective tissue structure. A pediatric skin atlas would be
able to provide normal skin references for studies onpathological
skin conditions related to disrupted growth and development,
including congenital melanocytic lesions, Spitz nevi, epidermal
nevi, vascular tumors, vascular malformations, and lipomas and
also would be able to inform research on tissue-engineered
skin substitutes for wounds and impaired barrier conditions.
Pediatric Cancer
Childhood cancers are the leading cause of disease-related
mortality, where leukemia and brain tumors lead the list as
the deadliest pediatric cancers in absolute numbers (NCI,
2018). Childhood is one of the two peaks of leukemia inci-
dence, and a number of developmental hematopoietic abnor-
malities first manifest in childhood. Children’s and adult tumors
are genomically and genetically distinct (Ma et al., 2018; Liu
et al., 2016) and children tumors have a strong developmental
component. The age at which a child develops leukemia or
neuroblastoma is one of the strongest predictors of outcome
(Riehm et al., 1987; Mastrangelo et al., 1986; Smith et al.,1996). While several frequent leukemia-imitating genomic al-
terations are common between adults and children, specific
classes of variation, such as splicing factor mutations in acute
myeloid leukemia, are restricted to adults (Farrar et al., 2016).
A recent study using single cells comparing normal renal tissue
and renal tumors from both children and adults has shown that
adult kidney cancers appear to be derived from a subtype of
proximal convoluted tubular cells, while pediatric Wilms tu-
mors likely arise from aberrant fetal cells (Young et al., 2018).
Single-cell studies of pediatric H3K27M diffuse gliomas have
identified predominant oligodendrocyte precursor cell sub-
populations, from which stem-like cycling cells propagate the
disease (Filbin et al., 2018). A subset of metastatic neuroblas-
toma often spontaneously regresses without treatment in
infants under 12 months of age, but not in older children, high-
lighting the developmental influence on survival in patients with
this cancer (Nickerson et al., 2000).
Although not in the direct scope of profiling normal tissues, the
PCA can partner with researchers driving single-cell pediatric
tumor atlases to help source normal tissues for comparison.
These comparisons would help to produce high-resolution in-
sights into oncogenic mechanisms at the sub-clonal level. Any
pediatric tumor atlas would benefit from the PCA’s normal sin-
gle-cell profiles and can compare these to the most common
cancers of childhood including, but not limited to, leukemia, neu-
roblastoma, high-grade glioma, medulloblastoma, neurofibro-
matosis, and ependymoma. The comprehensive analysis of
very high-risk pediatric lymphoblastic leukemia, neuroblastoma,
and high-grade glioma is currently part of the NIH’s Cancer
Moonshot Human Tumor Atlas Network (HTAN). A PCA would
provide a much-needed framework of normal development
that will be needed to understand how aberrant development
leads to pediatric cancer.Summary
Pediatric tissues are different from adult tissues in several
important ways, most notably because they are still undergo-
ing development. Here, we highlight several unique opportu-
nities and advantages in the PCA for the medical and research
communities. Systematic analysis of pediatric tissues and or-
gan systems at different developmental stages would improve
our understanding of cell-type-specific responses to clinical
situations, even those where collecting single-cell data on
temporal and perturbational responses is infeasible. The
PCA would provide integrated observational atlas data and
develop algorithms to mine these data in the context of both
early and advanced developmental dynamic processes.
Deep single-cell-based profiling of pediatric tissues of both
dissociated cells and cells within tissues, the goal of the
PCA as part of the overall HCA effort, would provide the
framework to define and characterize cell types, cell states,
and their interactions that, together, lead to normal childhood
development and are subverted by childhood disease states
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